Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon-beta(1b) treatment in neuromyelitis optica.
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Information for healthcare professionals: Rituximab
Statement on a nonproprietary name adopted by the USAN Council
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
Visualization of myelination in GFP-transgenic zebrafish.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.

Pages